0001817713-21-000001.txt : 20210312 0001817713-21-000001.hdr.sgml : 20210312 20210312163603 ACCESSION NUMBER: 0001817713-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210312 DATE AS OF CHANGE: 20210312 EFFECTIVENESS DATE: 20210312 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Janux Therapeutics, Inc. CENTRAL INDEX KEY: 0001817713 IRS NUMBER: 822289112 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-392167 FILM NUMBER: 21737974 BUSINESS ADDRESS: STREET 1: 11099 TORREY PINES PARK ROAD CITY: SAN DIEGO STATE: CA ZIP: 92037 BUSINESS PHONE: 858-750-4700 MAIL ADDRESS: STREET 1: 11099 TORREY PINES PARK ROAD CITY: SAN DIEGO STATE: CA ZIP: 92037 D 1 primary_doc.xml X0708 D LIVE 0001817713 Janux Therapeutics, Inc. 11099 NORTH TORREY PINES ROAD SAN DIEGO CA CALIFORNIA 92037 858-750-4700 DELAWARE None None Corporation true 2017 David Campbell, Ph.D. 11099 North Torrey Pines Road Suite 290 La Jolla CA CALIFORNIA 92037 Executive Officer Director Jay Lichter, Ph.D. 11099 North Torrey Pines Road Suite 290 La Jolla CA CALIFORNIA 92037 Director Stefan Heller 11099 North Torrey Pines Road Suite 290 La Jolla CA CALIFORNIA 92037 Director Tighe Reardon 11099 North Torrey Pines Road La Jolla CA CALIFORNIA 92037 Executive Officer Jake Simson, Ph.D. 11099 North Torrey Pines Road La Jolla CA CALIFORNIA 92037 Director Peter Thompson, M.D. 11099 North Torrey Pines Road La Jolla CA CALIFORNIA 92037 Director Biotechnology Decline to Disclose 06b false 2021-03-01 false true false 0 56000030 56000030 0 false 7 0 0 0 false Janux Therapeutics, Inc. /s/ David Campbell David Campbell, Ph.D. President and CEO 2021-03-09